Cardiac resynchronization therapy in mild heart failure: A review of the reverse and MADIT-CRT trials

Current Cardiology Reports

Volumn 12, Issue 5, 2010, Pages 367-373

  Reynolds, Carl R ^a   Gold, Michael R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Artificial; Cardiac pacemaker; Congestive heart failure; Left bundle branch block; Left ventricle

Indexed keywords

ACUTE HEART FAILURE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERALL SURVIVAL; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; HEART FAILURE; HEART VENTRICLES; HUMANS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956262658     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0125-6     Document Type: Review

References (35)

1. AE Epstein JP DiMarco KA Ellenbogen, et al. 2008 ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 e350 e408 10.1161/CIRCUALTIONAHA.108.189742 18483207 This is the most recent official society guidelines for cardiac device therapy
2. C Daubert MR Gold WT Abraham, et al. 2009 Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 1837 1846 10.1016/j.jacc.2009.08.011 19800193 This is a report of European cohort of REVERSE showing significant difference in the percent worsened in the clinical composite score
3. C Linde WT Abraham MR Gold, et al. 2008 Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 1834 1843 10.1016/j.jacc.2008.08.027 19038680 This is the main REVERSE trial citation
4. AJ Moss WJ Hall DS Cannom, et al. 2009 Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329 1338 10.1056/NEJMoa0906431 19723701 This is the main MADIT-CRT trial citation
5. M St John Sutton S Ghio T Plappert, et al. 2009 Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure Circulation 120 1858 1865 10.1161/CIRCULATIONAHA.108.818724 19858419 This is a focused echocardiographic analysis of the REVERSE trial
6. S Cazeau C Leclercq T Lavergne, et al. 2001 Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 873 880 10.1056/NEJM200103223441202 1:STN:280:DC%2BD3M7nsV2ltw%3D%3D 11259720
7. JG Cleland JC Daubert E Erdmann, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 1539 1549 10.1056/NEJMoa050496 1:CAS:528:DC%2BD2MXjtFGnsLo%3D 15753115 This is a study of 813 NYHA III/IV HF patients randomized to optimal medical therapy with or without CRT. Mortality was significantly reduced with CRT (20% vs 30%, P < 0.002), and quality-of-life scores, EF, and end-systolic volume index were all improved with CRT
8. MR Bristow LA Saxon J Boehmer, et al. 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140 2150 10.1056/NEJMoa032423 1:CAS:528: DC%2BD2cXktF2isrc%3D 15152059
9. WT Abraham JB Young AR Leon, et al. 2004 Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure Circulation 110 2864 2868 10.1161/01.CIR.0000146336.92331.D1 15505095
10. SL Higgins JD Hummel IK Niazi, et al. 2003 Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 1454 1459 10.1016/S0735-1097(03)01042-8 14563591
11. JF Beshai RA Grimm SF Nagueh, et al. 2007 Cardiac-resynchronization therapy in heart failure with narrow QRS complexes N Engl J Med 357 2461 2471 10.1056/NEJMoa0706695 1:CAS:528:DC%2BD2sXhsVemtbfO 17986493 This is an important negative result in a trial of 172 patients with narrow QRS but moderate to severe HF. Echocardiography was used to identify mechanical dyssynchrony. No significant difference was found in peak VO2 with CRT, providing evidence against use of CRT in HF patients and narrow QRS (RETHINQ)
12. ES Chung AR Leon L Tavazzi, et al. 2008 Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2608 2616 10.1161/ CIRCULATIONAHA.107.743120 18458170
13. J Gorcsan 3rd M Tanabe GB Bleeker, et al. 2007 Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy J Am Coll Cardiol 50 1476 1483 10.1016/j.jacc.2007.06.043 17919568
14. J Gorcsan 3rd T Abraham DA Agler, et al. 2008 Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting-a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society J Am Soc Echocardiogr 21 191 213 10.1016/j.echo.2008.01.003 18314047
15. MS Suffoletto K Dohi M Cannesson, et al. 2006 Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy Circulation 113 960 968 10.1161/CIRCULATIONAHA.105.571455 16476850
16. GB Bleeker ER Holman P Steendijk, et al. 2006 Cardiac resynchronization therapy in patients with a narrow QRS complex J Am Coll Cardiol 48 2243 2250 10.1016/j.jacc.2006.07.067 17161254
17. GB Bleeker MJ Schalij E Boersma, et al. 2007 Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 99 68 74 10.1016/j.amjcard.2006.07.068 17196465
18. MR Gold C Linde IF Lozano, et al. 2009 Relationship of QRS duration to reverse remodeling with cardiac resynchronization therapy in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) trial J Am Coll Cardiol 53 A135
19. MR Gold C Linde IF Lozano, et al. 2009 Impact of QRS duration on clinical response with cardiac resynchronization therapy: results from the REVERSE trial [abstract] Circulation 120 S814 10.1161/CIRCULATIONAHA.109.854554
20. GB Bleeker MJ Schalij ER Holman, et al. 2006 Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy Am J Cardiol 98 230 235 10.1016/j.amjcard.2006.01.080 16828599
21. H Skali MA Pfeffer J Lubsen SD Solomon 2006 Variable impact of combining fatal and nonfatal end points in heart failure trials Circulation 114 2298 2303 10.1161/CIRCULATIONAHA.106.620039 17116781
22. M Packer 2001 Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure J Card Fail 7 176 182 10.1054/jcaf.2001.25652 1:CAS:528:DC%2BD3MXlt1egsrg%3D 11420770
23. WH Sauer MR Bristow 2008 The Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial in perspective J Interv Card Electrophysiol 21 3 11 10.1007/s10840-007-9170-5 18044015
24. CM Yu GB Bleeker JW Fung, et al. 2005 Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy Circulation 112 1580 1586 10.1161/CIRCULATIONAHA.105. 538272 16144994
25. JG Cleland JC Daubert E Erdmann, et al. 2006 Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 1928 1932 10.1093/eurheartj/ehl099 16782715
26. WT Abraham WG Fisher AL Smith, et al. 2002 Cardiac resynchronization in chronic heart failure N Engl J Med 346 1845 1853 10.1056/NEJMoa013168 12063368
27. DV Exner 2009 Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure? J Am Coll Cardiol 54 1847 1849 10.1016/j.jacc.2009.08.013 19800192
28. M Jessup 2009 MADIT-CRT-breathtaking or time to catch our breath? N Engl J Med 361 1394 1396 10.1056/NEJMe0907335 1:CAS:528:DC%2BD1MXht1Cks77I 19723700
29. TJ Wang JC Evans EJ Benjamin, et al. 2003 Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 977 982 10.1161/01.CIR.0000085166.44904.79 12912813
30. KA Ammar SJ Jacobsen DW Mahoney, et al. 2007 Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community Circulation 115 1563 1570 10.1161/CIRCULATIONAHA.106.666818 17353436
31. AS Tang GA Wells M Arnold, et al. 2009 Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design Curr Opin Cardiol 24 1 8 10.1097/HCO.0b013e32831bc63b 1:CAS:528:DC%2BD1MXhsV2js7nF 19102034
32. RN Doshi EG Daoud C Fellows, et al. 2005 Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) J Cardiovasc Electrophysiol 16 1160 1165 10.1111/j.1540-8167.2005.50062.x 16302897
33. BL Wilkoff JR Cook AE Epstein, et al. 2002 Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA 288 3115 123 10.1001/jama.288.24.3115 12495391
34. AB Curtis PB Adamson E Chung, et al. 2007 Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale J Cardiovasc Electrophysiol 18 965 971 10.1111/j.1540-8167.2007. 00907.x 17655677
35. RC Funck JJ Blanc HH Mueller, et al. 2006 Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study Europace 8 629 635 10.1093/europace/eul075 16864616